Pertuzumab-associated diarrhea in HER2/neu-positive breast cancer patients: A comparison of trials to actual practice:

Olga Yankulina,Andrew R. Zullo,Sarah E Cabral,Justin P. Huynh,Jennifer A Hutchinson,Mary L. Lopresti,Mary Anne Fenton,Christine Berard-Collins

Pertuzumab-associated diarrhea in HER2/neu-positive breast cancer patients: A comparison of trials to actual practice:

2019

Olga Yankulina
Andrew R. Zullo
Sarah E Cabral
Justin P. Huynh
Jennifer A Hutchinson
Mary L. Lopresti
Mary Anne Fenton
Christine Berard-Collins

BackgroundAlthough landmark trials in the metastatic (CLEOPATRA) and neo-adjuvant (NeoSphere; TRYPHAENA) settings identified all-grade diarrhea as a pertuzumab-associated adverse event, it was not ...

Keywords:

Breast cancer
Pertuzumab
Diarrhea
Oncology
Intensive care medicine
HER2/neu
Internal medicine
Medicine
HER2/Neu Positive
Adverse effect
actual practice

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations